≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Adenocarcinoma of small intestine

EFO Endpoint Browser PheWeb

C3_SMALL_INTESTINE_ADENO

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C17
  • Cancer registry: Morphology ICD-O-3 — 8140|8144|8145
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

119

4. Check minimum number of events

None

119

5. Include endpoints

None

119

6. Filter based on genotype QC (FinnGen only)

106

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 106 46 60
Unadjusted period prevalence (%) 0.02 0.02 0.03
Median age at first event (years) 68.63 66.48 70.27

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
109
Matched controls
1090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
93.7
76
*
A03FA01
ATC
metoclopramide; systemic, rectal
24.0
66.2
69
73
L01BC06
ATC
capecitabine; oral
+∞
64.0
55
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
31.4
53.8
39
19
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
53.6
47
*
8140/3-C17.0
ICD-O-3
Adenocarcinoma, NOS, of duodenum
+∞
49.9
44
*
JFB00
NOMESCO Finland
Partial resection of small intestine
377.1
48.1
45
*
H02AB02
ATC
dexamethasone; systemic
188.4
45.9
45
*
JN4AD
NOMESCO Finland
Body CT examination
21.2
45.9
40
29
A04AA02
ATC
granisetron; systemic, transdermal
+∞
40.1
36
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
536.2
38.6
36
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
53.6
35.0
41
12
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
34.2
31
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
34.2
31
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
34.2
31
*
JN3AD
NOMESCO Finland
Abdominal CT examination
10.7
31.1
44
65
Z51.5
ICD-10 Finland
Palliative care
15.1
30.8
31
28
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
30.7
28
*
8140/3-C17.9
ICD-O-3
Adenocarcinoma, NOS, of small intestine, NOS
+∞
30.7
28
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
71.2
28.0
31
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
7.3
23.8
71
223
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
22.7
21
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
21.6
20
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
22.3
21.2
31
19
JN4BD
NOMESCO Finland
Extensive body CT
20.0
21.1
32
22
8140/3-C17.2
ICD-O-3
Adenocarcinoma, NOS, of ileum
+∞
20.4
19
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.6
19.6
34
61
N02AA05
ATC
oxycodone; systemic
6.5
19.6
44
103
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
47.9
19.5
23
6
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
31.9
19.3
25
10
WX402
NOMESCO Finland
General anaesthesia
5.9
17.5
44
113
8140/3-C17.1
ICD-O-3
Adenocarcinoma, NOS, of jejunum
+∞
17.1
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
17.1
16
*
A04AA01
ATC
ondansetron; systemic, rectal
21.2
17.1
25
15
B01AB10
ATC
tinzaparin; parenteral
7.5
16.7
28
48
JAH00
NOMESCO Finland
Laparotomy
23.9
16.4
23
12
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
7.8
16.3
26
42
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
45.4
16.0
19
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
34.5
15.8
20
7
JAH01
NOMESCO Finland
Laparoscopy
20.8
15.1
22
13
WX408
NOMESCO Finland
General anesthesy, balanced
4.9
14.3
45
137
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
39.8
14.0
17
5
WZC00
NOMESCO Finland
Treatment plan or consultation
4.6
13.9
52
181
A04AA55
ATC
palonosetron, combinations; systemic
+∞
13.8
13
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
13.8
13
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
159.0
13.8
14
*
D64.9
ICD-10 Finland
Anaemia, unspecified
5.6
13.1
30
69
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
+∞
12.7
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
12.7
12
*
UJF32
NOMESCO Finland
Coloscopy
4.3
12.5
47
162
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
53.0
12.2
14
*
R4190
NOMESCO Finland
Nutritional therapy
19.3
12.2
18
11
B01AB05
ATC
enoxaparin; parenteral
4.0
11.5
55
223
WZC30
NOMESCO Finland
Teaching
4.7
11.3
32
88
K56.7
ICD-10 Finland
Ileus, unspecified
24.5
11.0
15
7
ZX120
NOMESCO Finland
Intravenous
9.1
10.9
23
31
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
121.2
10.6
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
121.2
10.6
11
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
10.6
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.6
10
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
26.5
10.5
14
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.2
10.2
24
56
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
29.2
10.1
13
5
Z31.5
ICD-10 Finland
Genetic counselling
15.4
10.0
16
12
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
9.8
37
125
TPH04
NOMESCO Finland
Cathetrisation of vein
4.0
9.6
35
115
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.5
9
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.4
9.3
28
80
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.4
9.2
56
257
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
26.7
9.1
12
5
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
26.7
9.1
12
5
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.5
8.9
25
67
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
30.2
8.7
11
*
WX600
NOMESCO Finland
Single shot through catheter
97.3
8.5
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.4
8.5
17
21
ZXD05
NOMESCO Finland
Urgent procedure
3.3
8.5
47
202
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.9
7.9
27
84
R4110
NOMESCO Finland
Physiotherapy
3.2
7.8
44
189
A02BC02
ATC
pantoprazole; systemic
3.8
7.5
88
573
UJF92
NOMESCO Finland
Capsular endoscopy
17.3
7.4
11
7
A04AD12
ATC
aprepitant; systemic
+∞
7.4
7
*
115
Kela drug reimbursment
Breast cancer
+∞
7.4
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.4
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.4
7
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
7.4
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.4
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.4
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.4
7
*
L03AA02
ATC
filgrastim; parenteral
+∞
7.4
7
*
JDE00
NOMESCO Finland
Gastrojejunostomy
+∞
7.4
7
*
WW500
NOMESCO Finland
Blood transfusion
13.3
7.3
12
10
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
32.4
7.3
9
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
15.1
7.1
11
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
6.9
30
109
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
42.8
6.9
8
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
42.8
6.9
8
*
ZXE00
NOMESCO Finland
One hour or less
2.9
6.8
53
270
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.6
6.6
17
42
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.1
6.5
13
16
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
74.0
6.5
7
*
WF002
NOMESCO Finland
Radical radiotherapy
74.0
6.5
7
*
D50.8
ICD-10 Finland
Other iron deficiency anaemias
19.4
6.4
9
5
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
C17
ICD-10 Finland
Malignant neoplasm of small intestine
+∞
6.3
6
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
9.5
6.2
12
14
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.5
6.2
12
14
R11
ICD-10 Finland
Nausea and vomiting
3.9
6.2
20
59
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
6.2
54
288
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
8.0
6.1
13
18
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
6.0
49
252

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
23
21.03
40.04
1.6
1.2
—
—
—
0
0
47
67
11.57
34.45
7.2
1.8
0.19
0.22
g/l
1.20
47
56
86
382
6.93
18.04
4.9
2.3
—
—
estimate
—
0
0
50
142
5.66
17.78
1.8
1.3
—
—
—
0
0
69
268
5.29
16.58
4.6
2.0
—
—
—
0
0
83
386
5.82
15.64
15.6
3.5
32.45
35.62
g/l
4.44
83
361
46
134
5.21
15.60
14.7
5.9
102.96
103.84
mmol/l
0.44
46
134
65
259
4.74
14.65
7.0
3.7
—
—
—
0
0
45
144
4.62
13.30
5.9
2.0
0.80
0.82
mmol/l
0.99
45
133
23
22
12.92
13.03
1.5
1.3
150.73
324.00
ug/g
2.38
18
12
36
98
4.99
12.98
1.8
1.3
—
—
—
0
0
60
258
3.95
11.47
3.2
1.6
—
—
—
0
0
29
74
4.98
11.16
1.5
1.1
—
—
—
0
0
29
79
4.64
10.26
4.7
4.3
8.58
11.62
mmol/l
1.08
29
73
34
115
3.84
8.91
12.3
6.6
7.41
7.41
ph
0.07
17
66
80
472
3.61
8.46
10.8
5.4
1.18
1.21
mmol/l
2.35
74
406
82
495
3.65
8.28
22.2
5.6
3.61
4.29
e9/l
2.33
75
423
36
135
3.49
8.00
3.4
1.9
—
—
—
0
0
78
478
3.22
7.25
16.0
14.8
1.18
1.30
inr
2.05
69
399
52
257
2.96
7.12
14.5
5.1
—
—
—
0
0
25
81
3.71
6.84
12.6
8.0
—
—
—
0
0
53
286
2.66
5.88
5.4
4.9
—
—
—
0
0
67
406
2.69
5.87
5.3
5.0
8.71
9.05
%
0.33
62
377
65
403
2.52
5.21
5.3
5.0
0.70
0.64
%
0.33
60
372
8
6
14.24
5.16
2.1
1.3
22.50
30.17
umol/l
—
8
6
41
206
2.59
5.13
1.6
1.3
—
—
—
0
0
50
280
2.45
4.94
4.0
3.1
0.41
0.29
e6/l
0.26
41
199
55
322
2.43
4.92
4.0
3.3
17.22
264.17
e6/l
0.64
45
243
9
11
8.79
4.66
3.7
5.4
11.41
12.04
mg/l
—
9
11
33
159
2.54
4.42
3.3
3.1
1.61
2.05
e6/l
0.17
16
70
58
362
2.29
4.32
4.4
3.9
980.82
107.13
e6/l
0.44
45
254
48
282
2.25
4.08
5.8
3.0
7.39
7.40
ph
0.87
37
192
68
464
2.24
3.96
5.3
5.3
1.56
1.82
e9/l
1.75
58
407
67
455
2.23
3.94
5.3
5.2
0.59
0.60
e9/l
0.13
56
386
36
190
2.34
3.91
2.0
1.9
1475.81
1228.51
nmol/l
0.52
31
146
67
460
2.18
3.77
5.3
5.2
0.04
0.04
e9/l
0.51
55
391
68
473
2.16
3.66
5.5
5.1
0.18
0.21
e9/l
0.75
57
406
24
109
2.54
3.58
4.8
2.9
7.38
7.39
ph
0.20
13
62
10
23
4.68
3.40
6.2
1.7
61.00
15.80
u/ml
—
10
23
13
39
3.64
3.36
1.2
1.2
—
—
—
0
0
59
400
2.04
3.28
21.4
10.1
0.01
0.00
e9/l
0.49
47
323
24
115
2.39
3.19
1.4
1.7
—
—
—
0
0
45
287
1.97
2.88
3.7
2.9
—
—
—
0
0
5
6
8.65
2.77
3.0
2.7
1.80
0.83
index
—
5
6
63
456
1.90
2.72
3.0
2.2
92.05
97.61
pmol/l
0.44
42
225
10
30
3.56
2.68
4.9
1.7
—
—
—
0
0
75
889
0.50
2.67
4.4
5.8
4.23
4.50
mmol/l
1.16
67
822
28
154
2.10
2.66
1.8
1.5
29.27
29.08
s
0.09
28
147
34
202
1.99
2.63
4.1
3.7
108.77
297.08
ng/l
0.63
26
166
75
884
0.51
2.47
4.3
5.7
1.34
1.46
mmol/l
1.57
66
809
19
338
0.47
2.35
3.5
3.7
—
—
—
0
0
19
99
2.11
2.06
1.4
1.6
—
—
—
0
0
14
64
2.36
2.04
10.4
3.3
—
—
—
0
0
5
11
4.71
1.96
1.2
1.6
12.91
15.44
ug/l
—
5
11
5
11
4.71
1.96
3.0
2.5
14.00
13.50
index
—
5
6
5
11
4.71
1.96
2.4
1.3
1.72
2.06
mmol/l
—
5
11
5
11
4.71
1.96
1.0
1.1
—
—
—
0
0
79
902
0.55
1.93
5.1
6.7
2.49
2.59
mmol/l
0.39
69
830
73
850
0.57
1.89
4.0
4.8
1.24
1.30
mmol/l
0.27
64
770
14
68
2.21
1.79
3.6
2.8
2.00
0.68
%
—
6
14
15
76
2.13
1.74
1.3
1.3
—
—
—
0
0
10
43
2.46
1.64
1.3
1.4
—
—
—
0
0
12
57
2.24
1.62
3.9
2.2
0.68
0.61
%
0.34
12
57
13
64
2.17
1.62
3.1
2.6
0.80
0.21
%
—
5
14
13
66
2.10
1.50
3.8
2.8
0.40
0.08
%
—
5
12
12
59
2.16
1.50
3.9
2.2
0.81
1.24
%
1.79
12
59
13
74
1.86
1.12
1.3
1.3
—
—
—
0
0
26
181
1.57
1.12
1.4
1.4
2.54
2.97
g/l
0.49
14
102
49
393
1.45
1.08
5.9
3.5
6.06
6.13
ph
0.19
31
219
12
68
1.86
1.05
1.3
1.5
—
—
—
0
0
27
193
1.53
1.04
3.8
3.9
—
—
—
0
0
29
217
1.46
0.90
2.0
1.8
363.05
412.81
pmol/l
0.63
22
176
34
267
1.40
0.81
5.1
3.0
—
0.00
—
0
7
76
830
0.72
0.77
5.6
5.4
2.01
1.95
mu/l
0.14
69
753
90
950
0.70
0.64
74.6
22.2
119.63
135.95
g/l
15.96
90
941
5
30
1.70
0.62
1.0
1.2
—
—
—
0
0
90
949
0.70
0.61
74.1
22.1
262.48
240.72
e9/l
2.38
90
934
90
949
0.70
0.61
76.3
22.5
36.55
40.48
%
12.66
90
940
90
949
0.70
0.61
73.7
22.0
29.77
30.41
pg
2.57
90
940
90
948
0.71
0.59
73.8
22.1
90.59
91.45
fl
1.04
90
939
32
262
1.31
0.58
2.0
2.5
341.07
364.72
umol/l
0.49
27
225
31
372
0.77
0.56
3.5
3.4
7.29
7.51
mmol/l
0.09
25
310
9
64
1.44
0.53
5.7
3.0
—
—
—
0
0
11
76
1.50
0.50
3.3
2.9
—
—
—
0
0
84
887
0.77
0.48
5.2
5.6
6.47
6.12
mmol/l
0.98
78
807
8
59
1.38
0.42
2.1
4.8
4.79
5.10
kpa
—
8
54
32
370
0.81
0.41
3.6
3.5
71.03
38.62
mg/l
0.33
23
247
90
938
0.77
0.40
64.7
20.0
77.76
81.61
umol/l
0.43
90
928
76
711
1.23
0.39
61.7
17.1
14.89
13.68
%
6.17
76
703
9
67
1.37
0.39
1.2
1.3
—
—
—
0
0
54
493
1.19
0.35
6.7
3.7
0.00
0.00
estimate
-0.00
13
101
35
393
0.84
0.32
5.0
4.5
1.89
2.03
ug/l
0.16
28
346
12
94
1.31
0.29
1.3
1.5
—
—
—
0
0
54
501
1.15
0.27
6.7
3.7
0.00
0.00
estimate
-0.00
14
103
6
80
0.74
0.25
1.5
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
54
507
1.13
0.21
6.6
3.7
0.00
0.08
estimate
0.79
13
93
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
90
873
1.18
0.21
49.4
14.2
37.54
23.73
mg/l
4.08
90
709
6
47
1.29
0.21
1.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
96.67
—
0
6
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
90
923
0.86
0.18
61.3
18.8
3.94
4.01
mmol/l
1.47
90
905
35
376
0.90
0.16
4.4
4.3
13.66
6.31
mg/mmol
0.37
25
242
90
921
0.87
0.16
62.2
18.7
138.17
139.74
mmol/l
5.87
90
903
9
78
1.17
0.16
2.9
2.5
5.78
5.99
ph
—
9
58
24
222
1.10
0.11
2.6
2.9
0.97
0.80
ug/l
0.36
14
146
5
44
1.14
0.10
1.0
1.2
—
95.44
—
0
17
67
689
0.93
0.10
4.6
4.2
14.40
15.00
pmol/l
1.54
60
619
89
904
0.92
0.08
43.5
12.9
—
—
—
0
0
29
279
1.05
0.04
6.2
3.7
0.00
0.00
estimate
-0.00
13
94
11
103
1.08
0.02
1.7
2.6
5.40
6.15
ug/l
0.15
11
90
38
374
1.02
0.00
7.8
3.6
0.00
0.03
estimate
0.49
12
76
26
263
0.99
0.00
7.4
3.2
0.00
0.00
estimate
-0.00
11
76
44
435
1.02
0.00
5.4
4.1
18.39
48.09
ng/l
2.62
34
334
0
5
0.00
-0.00
0.0
1.0
—
1440.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
175.47
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
2.60
—
0
6
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
21.17
—
0
6
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
7
71
0.98
-0.00
3.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
76.71
—
0
7
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_SMALL_INTESTINE_ADENO – Adenocarcinoma of small intestine

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).